Table 6. Proportion of patients with WD with normal ceruloplasmin levels in different regions.
Author | Country/time | Patients with Wilson’s disease | |
---|---|---|---|
Total number of patients | Patients with normal CP levels | ||
Brewer GJ et al. [24] | USA/1992 | 89 | 8(11.2%) |
Martins da Costa C [25] | United Kingdom/1992 | 17 | 3(17.6%) |
Steindl P et al. [18] | Germany/1997 | 55 | 15(27.3%) |
Merle U et al. [26] | Germany/2007 | 163 | 19(11.8)) |
Gheorghe L et al. [27] | Romania/2004 | 55 | 24(43.6%) |
Müller T et al. [28] | Austria/2007 | 35 | 9(25.7%) |
Manolaki N et al. [29] | Greece/2008 | 57 | 7(12.3%) |
Nicastro E et al. [30] | Italy/2010 | 40 | 2(5.0%) |
El-Karaksy H et al. [31] | Egypt/2011 | 54 | 1(1.9%) |
Taly AB et al. [32] | India/2007 | 282 | 19(6.9%) |
Rukunuzzaman MD [33] | Bangladesh/2015 | 100 | 27(27.0%) |
Lee BH et al. [21] | Korea/2011 | 237 | 0(0.0%) |
Mak CM et al. [4] | Hong Kong/2008 | 57 | 1(1.8%) |
Liu Y et al. [23] | China/2015 | 77 | 2(2.6%) |
Feng L et al. [22] | China/2016 | 126 | 0(0.0%) |
This study | China/2017 | 297 | 3(1.0%) |